TrialJournal of human hypertension2005

The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly.

J Lundkvist et al.PubMed ↗Publisher ↗

No numbers read from the abstract.